指南与共识心血管技术与安全PETCTMR

心脏PET/CT成像操作建议:炎症性、感染性、浸润性和神经支配异常(4Is)相关心血管疾病的标准化——EACVI与EANM联合协作摘要

Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary.
指南 / 共识 · Eur Heart J Cardiovasc Imaging · 2020-01-01

本文为EACVI与EANM联合发布的标准化文件摘要,针对炎症性、感染性、浸润性和神经支配异常(4Is)相关心血管疾病,制定PET/(诊断性)CT成像操作规范。标准应应用于临床实践并整合至临床(多中心)试验中,以实现操作和判读的最佳标准化。重点聚焦于使用[18F]FDG的操作流程,同时也描述了[18F]FDG以外的4Is PET放射性药物。

要点

  • 4Is相关心血管疾病的诊断与管理复杂,常需多学科专家团队协作。
  • 新标准适用于PET/CT和PET/MR,应在多模态影像框架下于临床实践和临床试验中应用。
  • 操作规范重点为[18F]FDG,同时涵盖[18F]FDG以外的4Is PET放射性药物。

核心结论

  • 本标准化文件应应用于临床实践并整合至临床(多中心)试验中,以实现操作和判读的最佳标准化。
  • 新标准适用于PET/CT和PET/MR,应在多模态影像框架下用于4Is心血管适应证的临床实践和临床试验。
  • 4Is相关心血管疾病的诊断与管理通常复杂,常需多学科专家团队协作。

研究设计与样本

  • 本文为EACVI与EANM联合协作的标准化推荐摘要,已于European Journal of Nuclear Medicine and Molecular Imaging发表。
  • 原文未报告样本量、中心数及参考标准。

临床应用与阅片要点

  • 操作规范重点为使用[18F]-2-氟-2-脱氧葡萄糖([18F]FDG)的流程。
  • 本摘要文件也描述了[18F]FDG以外的4Is PET放射性药物;这些新型示踪剂目前主要用于早期临床试验,部分多中心试验正在进行中。
  • 新标准应在多模态影像框架下用于PET/CT和PET/MR的4Is心血管适应证临床实践和临床试验。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

With this summarized document we share the standard for positron emission tomography (PET)/(diagnostic)computed tomography (CT) imaging procedures in cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with dysfunctional innervation (4Is) as recently published in the European Journal of Nuclear Medicine and Molecular Imaging. This standard should be applied in clinical practice and integrated in clinical (multicentre) trials for optimal standardization of the procedurals and interpretations. A major focus is put on procedures using [18F]-2-fluoro-2-deoxyglucose ([18F]FDG), but 4Is PET radiopharmaceuticals beyond [18F]FDG are also described in this summarized document. Whilst these novel tracers are currently mainly applied in early clinical trials, some multicentre trials are underway and we foresee in the near future their use in clinical care and inclusion in the clinical guidelines. Diagnosis and management of 4Is related cardiovascular diseases are generally complex and often require a multidisciplinary approach by a team of experts. The new standards described herein should be applied when using PET/CT and PET/magnetic resonance, within a multimodality imaging framework both in clinical practice and in clinical trials for 4Is cardiovascular indications.

来源:Eur Heart J Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Slart RHJA, Glaudemans AWJM, Gheysens O, et al. Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary. Eur Heart J Cardiovasc Imaging. 2020. PMID: 33245759. doi:10.1093/ehjci/jeaa299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。